FDA Device recall Z-1873-2014
Glucose Hexokinase Liquid Reagent For the in vitro quantitative determination of Glucose in serum
- FDA Device
- Class II
- terminated
- Published 2014-07-02
On 2014-07-02 the FDA classified a Class II recall of Glucose Hexokinase Liquid Reagent For the in vitro quantitative determination of Glucose in serum by Jas Diagnostics, citing JAS Diagnostics, Inc. of Miami Lakes, FL is recalling their Glucose Hexokinase reagent due to certain lots not performing according to their specifications.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1873-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-04-07 |
| Published | 2014-07-02 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Jas Diagnostics |
| Distribution | CA, FL, GA, KY, MI, MN, NC, NJ, NV, NY, OK, PA, PR, TN, TX, VA, WV |
Product
Glucose Hexokinase Liquid Reagent For the in vitro quantitative determination of Glucose in serum.
Reason
JAS Diagnostics, Inc. of Miami Lakes, FL is recalling their Glucose Hexokinase reagent due to certain lots not performing according to their specifications.
Identifiers
| code_info | LOTS#: N060208K, N060209K, N0602010K, N0902014K, N0902015K, N0902016K, N0902017K, N0902018K, N0902019K, N0902020K, N110…LOTS#: N060208K, N060209K, N0602010K, N0902014K, N0902015K, N0902016K, N0902017K, N0902018K, N0902019K, N0902020K, N1102021K, N1102022K, N1102023K, N1102024K, N1102025K, N1102026K, N1102027K, N1102028K, N1102029K. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1873-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.